UnfairGaps
🇦🇺Australia

Revenue Leakage from Unappealed Denials

1 verified sources

Definition

Labs lose revenue when denials are not appealed in time; industry data shows hospitals spend billions overturning denials, with partial success leading to leakage.

Key Findings

  • Financial Impact: AUD 10B+ annual spend to overturn denials; 20% claims denied, 60% not resubmitted[3]
  • Frequency: Ongoing, per denied claim cohort
  • Root Cause: Manual workflows, no automated tracking of appeal deadlines

Why This Matters

This pain point represents a significant opportunity for B2B solutions targeting Medical and Diagnostic Laboratories.

Affected Stakeholders

Accounts Receivable Specialist, Compliance Officer

Action Plan

Run AI-powered research on this problem. Each action generates a detailed report with sources.

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Related Business Risks